搜尋結果
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's ...
CNBC· 3 日前Big pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall ...
Ozempic Maker Novo Nordisk Halts Roof Repairs for Probe After Factory Fire
Bloomberg· 2 日前Novo Nordisk A/S has halted roof repairs across its sites as it investigates last week’s fire ...
Nvidia Stock Slips As Wall Street Awaits Blockbuster Earnings
Forbes· 6 日前Nvidia stock slumped Tuesday ahead of its hotly anticipated earnings report due this week, as the top investor pick for ...
Lilly Invests $5.3 Billion to Boost Weight-Loss Drug Supply
Bloomberg· 2 日前Have a confidential tip for our reporters? Eli Lilly & Co. will spend $5.3 billion to boost ...
Nvidia's split of soaring stock could boost retail investor appeal, Dow chances
Reuters· 3 日前, opens new tab plan to split its stock after the stunning rise in the chipmaker's share ...
GSK Faces Whistleblower Suit From Lab That Exposed Zantac Risk
Bloomberg· 6 日前GSK Plc is facing a whistleblower lawsuit that could potentially cost it billions of dollars ...
As trade war brews, EU scrambles to gauge what Chinese retaliation lies ahead
South China Morning Post· 5 日前Fast-forward 11 years, European officials are experiencing déjà vu. New fears of a trade war ...
Council Post: Embracing AI: Transforming Finance Workflows In The Age Of Automation
Forbes· 3 日前The integration of artificial intelligence (AI) into financial operations has become not just a ...
百濟神州營收增七成 逆市擴張策略見回報?
The Bamboo Works 詠竹坊 via Yahoo財經香港· 4 日前一方面,這間公司手持年收入超過10億美元的「重磅炸彈」藥物(Blockbuster drugs),營收連年創新高;另一方面,它堪稱最捨得花錢投入研發的藥企,公司成立以來 ...
Sanofi Drug Shows Promise in Asthma After Blood Disorder Success
Bloomberg· 4 日前A Sanofi experimental drug showed promise in treating asthma, supporting the French drugmaker’s ...